Dr. Nana Jin | Hearing loss | Best Researcher Award

Posted on by Pencis

Dr. Nana Jin | Hearing loss | Best Researcher Award

Institute for Translational Neuroscience of Affiliated Hospital 2 of Nantong University | China

Author Profile

Scopus

Orcid ID

🧠 NANA JIN: PIONEER IN TRANSLATIONAL NEUROSCIENCE

🎓 EARLY ACADEMIC PURSUITS

Nana Jin was born on March 21, 1986, in Anyang, Henan, China. Her academic journey began with a strong foundation in the life sciences. She earned her Bachelor of Science from the Life Science College of Henan Normal University in 2007. Driven by a passion for neuroscience, she pursued a Master of Science at the Key Laboratory of Neuroregeneration of Nantong University, where she honed her research skills and built the groundwork for her future contributions. She later achieved her Ph.D. in Medicine from the Medical School of Nantong University in 2022, deepening her expertise in neurodegenerative diseases.

🧪 PROFESSIONAL ENDEAVORS

Nana Jin's professional career spans over a decade of dedication to neurological research. She began as a junior researcher (2010–2014) at the Key Laboratory of Neuroregeneration, where she contributed to vital studies on neuronal repair. She was promoted to Assistant Researcher in 2014 and continued her work there until 2023.

In 2023, she transitioned to the Institute for Translational Neuroscience at the Affiliated Hospital 2 of Nantong University, where she initially served as an Assistant Researcher. Later that year, she was elevated to the role of Associate Researcher, reflecting her growing impact and leadership in the field.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON HEARING LOSS

Nana Jin's research centers on neurodegeneration, particularly the molecular mechanisms underlying tau pathology in Alzheimer’s disease and related disorders. Her investigative focus includes:

  • The inhibition of tau propagation under cerebral hypoperfusion.

  • The interplay between GSK3β and PP2A methyltransferase.

  • The role of TDP-43 and its cross-pathological associations with tau.

  • Targeted monoclonal antibody therapies against tau protein.

Her research also extends to diabetes-related gene function and kinase regulation in neurodegenerative contexts.

🌍 IMPACT AND INFLUENCE

Dr. Jin has played critical roles in several national-level research projects, both as Principal Investigator and as a key participant. Her work contributes significantly to our understanding of Alzheimer’s disease, and she has been part of innovative strategies for early intervention and therapeutic targeting. Her team’s achievements have laid the groundwork for clinical applications aimed at halting or reversing pathological brain changes.

📊 ACADEMIC CITES AND PROJECT FUNDING

Nana Jin’s work has been supported by prestigious grants such as:

  • National Natural Science Foundation General and Youth Projects.

  • Jiangsu Provincial Natural Science Foundation.

  • High-Level Talent Introduction Project.

She has been awarded over 4 million RMB in competitive research funding, demonstrating both the trust of the scientific community and the value of her contributions. Her published findings are frequently cited in the neurodegeneration research field, contributing to the global body of knowledge.

🏆 AWARDS AND HONOURS

Nana Jin's scientific excellence has earned her multiple accolades:

  • 🥇 2018 Jiangsu Provincial Government Scholarship for Overseas Study

  • 🏅 2015 Natural Science Award (Second Prize) from the Ministry of Education for her work on tau protein metabolism

  • 👩‍🔬 2015 Outstanding Scientific Innovation Team recognition from Jiangsu Higher Education Institutions

These honors reflect her recognized role in advancing neuroscience both in China and internationally.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Jin is poised to continue her trailblazing work in translational neuroscience, particularly in the prevention and treatment of Alzheimer’s disease. With her strong academic background, extensive research experience, and continued support from key institutions, she is expected to contribute significantly to future breakthroughs in neurodegenerative disease therapy and molecular brain research.

📑NOTABLE PUBLICATIONS

"Genome-wide profiling and functional characterization of circular RNAs in neural development and injury: insights from a rat model research" 

  • Authors: J., Yang, Jian , N., Jin, Nana , S., Zhang, Shuqiang, Z., Cui, Zhiming , L., Xu, Lian
  • Journal: Cellular and Molecular Life Sciences
  • Year: 2025

"Integrative mRNA and miRNA Expression Profiles from Developing Zebrafish Head Highlight Brain-Preference Genes and Regulatory Networks " 

  • Authors: S., Zhang, Shuqiang , J., Yang, Jian , J., Xu, Jie , N., Jin, Nana , X., Li, Xiaoyu
  • Journal: Molecular Neurobiology
  • Year: 2025

"From microsphere synthesis to neural tissue regeneration: Unraveling the potentials and progress" 

  • Authors: Y., Liu, Yaqiong , Y., Shang, Yuqing , Z., Wang, Zhen , Y., Yang, Yumin , G., Li, Guicai

Junhua Wu | Tumor Gene Therapy | Excellence in Innovation

Posted on by Pencis

Prof Junhua Wu | Tumor Gene Therapy | Excellence in Innovation

Nanjing University | China

Author Profile

Scoups

Orcid ID

JUNHUA WU: PIONEERING RESEARCHER IN BIOMECHANICS AND ONCOLOGY 🔬

EARLY ACADEMIC PURSUITS 🎓

Junhua Wu embarked on his academic journey at Nanjing University (NJU), where he earned both his BSc in Life Sciences (1998–2002) and PhD in Life Sciences (2002–2007). His doctoral studies laid a strong foundation in molecular biology and biomechanics, equipping him with the expertise to make significant contributions to scientific research.

PROFESSIONAL ENDEAVORS 🏅

Following his graduation in June 2007, Junhua Wu remained at Nanjing University as a faculty member. His academic career has progressed steadily:

  • Lecturer (Since September 2007)
  • Associate Professor (Since December 2014)
  • Professor (Since December 2019)

He has received research funding from prestigious sources such as the National Natural Science Foundation of China, Key R&D Plan of Jiangsu Province, Natural Science Foundation of Jiangsu Province, and the Doctoral Program Fund of the Ministry of Education.

As an esteemed scholar, Professor Wu has published over 50 SCI papers in high-impact journals such as Nature Communications and holds 17 national invention patents. He has also contributed to academia through the compilation and translation of scientific monographs. His editorial roles include serving on the boards of Translational Oncology, Biocell, and Discovery Medicine.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR GENE THERAPY🔍

Professor Wu has made groundbreaking contributions in biomechanics, material science, and oncology. His research interests focus on protein hydrogels, tumorigenesis mechanisms, and novel cancer therapies.

1. Creation and Application of Hydrogels 💧

His work on protein hydrogels was a pioneering achievement in the field of biomechanics. He successfully demonstrated the ability to manipulate the mechanical properties of macromaterials by fine-tuning single protein molecules. His study, published in Nature Communications (2018), was a landmark contribution and has been cited 110 times.

His work was recognized in the 100th-anniversary special issue of international macromolecular science and was selected by the China Biomechanics Professional Committee as a key research advancement (2016–2018).

2. Mechanism of Tumorigenesis and Development 🧬

Professor Wu’s contributions to oncology include his exosome theory of sorafenib resistance in hepatocellular carcinoma, published in JECCR (2016). This study has been cited 113 times, influencing subsequent research on drug resistance in various cancers. His findings provided a new understanding of cancer cell communication and treatment resistance.

3. Innovative Cancer Therapies 💊

Professor Wu has developed novel strategies for cancer treatment, leading to over 20 invention patents and more than 30 high-impact SCI publications.

His research on mechanically stable peptide-graphene oxide hybrid hydrogels for drug delivery was highlighted as a Web of Science highly cited paper (Top 1% globally). This work demonstrated precise drug release mechanisms and was recognized for its potential to revolutionize targeted cancer therapy.

His “Trojan Horse” strategy for oncolytic virus delivery represents another major breakthrough. Published in JECCR (2019), this method involves using graphene nanoflakes to enhance viral delivery to tumors, significantly improving therapeutic outcomes.

IMPACT AND INFLUENCE 🌍

Professor Wu’s research has had a profound impact on multiple disciplines, including biomechanics, biomaterials, and oncology. His pioneering studies have inspired global researchers, with scholars from institutions such as the University of Wisconsin-Milwaukee drawing on his ideas for their work in Nature Communications, Science Advances, and PRL.

His cancer therapy innovations have been widely cited and applied by leading oncologists and material scientists. His findings have been positively reviewed and referenced in major scientific publications, solidifying his reputation as a thought leader in the field.

ACADEMIC CITATIONS 📑

Professor Wu’s work has received extensive recognition, accumulating hundreds of citations. Some notable statistics include:

  • 110+ citations for his 2018 Nature Communications paper on protein hydrogels.
  • 113+ citations for his 2016 JECCR paper on exosome-mediated drug resistance.
  • 122+ citations for his 2015 Nanoscale paper on peptide-graphene oxide hybrid hydrogels.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

Professor Junhua Wu’s legacy is defined by his interdisciplinary approach, bridging biomechanics, biomaterials, and cancer therapy. His innovative methodologies continue to shape biomedical engineering and oncology research.

Moving forward, he aims to:

  • Expand the applications of protein hydrogels for regenerative medicine and tissue engineering.
  • Advance tumor microecology studies to develop next-generation immunotherapies.
  • Refine oncolytic virus-based cancer treatments, enhancing their efficacy and clinical applications.

CONCLUSION 🏆

Junhua Wu stands as a pioneering figure in his fields of expertise. His work has redefined our understanding of mechanobiology and cancer treatment, earning him a place among the most influential scientists in modern biomedical research. His dedication to innovation ensures that his impact will continue to resonate for years to come.

NOTABLE PUBLICATIONS 📑

"SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy" 

  • Authors: P., Wang, Peng , J., Qiu, Jiannan , Y., Fang, Yuan , J., Wu, Junhua , C., Jiang,
  • Journal: Chunping Cell Death and Differentiation
  • Year: 2025

"Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy" 

  • Authors: K., Liu, Kua , L., Kong, Lingkai , H., Cui, Huawei , C., Jiang, Chunping , J., Wu, Junhua
  • Journal: Cell Reports Medicine
  • Year: 2024

"CuET overcomes regorafenib resistance by inhibiting epithelial-mesenchymal transition through suppression of the ERK pathway in hepatocellular carcinoma" 

  • Authors: D., Ma, Ding , S., Liu, Shuwen , K., Liu, Kua , J., Wu, Junhua , C., Jiang, Chunping
  • Journal: Translational Oncology
  • Year: 2024

"Toward Practical Applications of Engineered Living Materials with Advanced Fabrication Techniques" 

  • Authors: C., Lu, Chenjing , Y., Huang, Yaying , J., Cui, Jian , Y., Cao, Yi , S., Yin, Sheng
  • Journal: ACS Synthetic Biology
  • Year: 2024

"Structurally and mechanically tuned macroporous hydrogels for scalable mesenchymal stem cell-extracellular matrix spheroid production " 

  • Authors: S., Yin, Sheng , H., Wu, Haipeng , Y., Huang, Yaying , W., Wang, Wei , Y., Cao, Yi
  • Journal: Proceedings of the National Academy of Sciences of the United States of America
  • Year: 2024

Xu Zhou | Genetic Epidemiology | Best Researcher Award

Posted on by Pencis

Dr. Xu Zhou | Genetic Epidemiology | Best Researcher Award

Hunan Provincial Materinal and Child Health Care Hospital | China

Author Profile

Scopus

BIOGRAPHY OF XU ZHOU: DEDICATED RESIDENT PHYSICIAN IN PUBLIC HEALTH 🩺🌟

EARLY ACADEMIC PURSUITS 📚🎓

Xu Zhou, born in April 1991 in China, demonstrated an early commitment to advancing public health. Pursuing higher education with a Master’s degree in Public Health, he equipped himself with a solid foundation in health sciences. His academic endeavors at the master's level emphasized population health, disease prevention, and maternal and child care, preparing him for a meaningful career in healthcare.

PROFESSIONAL ENDEAVORS 🏥🔬

Currently serving as a Resident Physician at the prestigious Hunan Provincial Maternal and Child Health Care Hospital, Xu Zhou plays a vital role in improving the healthcare outcomes of mothers and children. His professional journey is marked by dedicated clinical practice and adherence to the highest standards of patient care. Working in a hospital recognized for excellence in maternal and child health, Xu Zhou contributes to the advancement of community health and clinical services.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETIC EPIDEMIOLOGY💡📖

Xu Zhou's contributions are centered on the intersection of clinical practice and public health research. His focus includes:

  • Enhancing healthcare systems for maternal and child health.
  • Promoting preventive measures to reduce mortality rates among vulnerable populations.
  • Exploring innovative strategies for improving overall public health outcomes in Hunan Province.

IMPACT AND INFLUENCE 🌍💪

Through his work as a resident physician, Xu Zhou impacts countless lives, providing essential medical services to mothers and children in need. His dedication has bolstered the healthcare infrastructure of the community he serves. As a professional in public health, he inspires colleagues to uphold the ethos of patient-centric care.

ACADEMIC CITATIONS AND SCHOLARLY CONTRIBUTIONS 📑✨

Though primarily focused on clinical work, Xu Zhou actively contributes to the field of public health through knowledge dissemination. His insights are integral to hospital workshops and training programs, fostering a culture of learning and skill development among healthcare professionals.

LEGACY AND FUTURE CONTRIBUTIONS 🚀🌟

Xu Zhou aspires to leave a lasting legacy as a compassionate physician and an advocate for maternal and child health. His future contributions are aimed at:

  • Innovating clinical practices to enhance maternal and child health outcomes.
  • Expanding his research portfolio to include broader public health challenges.
  • Mentoring young healthcare professionals to build a stronger healthcare workforce.

NOTABLE PUBLICATIONS 📑

"Fetal deaths from birth defects in Hunan Province, China, 2016–2020" 

  • Authors: Zhou, X. , He, J. , Wang, A. , Jiang, Y. , Shi, Y.
  • Journal: Scientific Reports
  • Year: 2024

"Prevalence and death rate of birth defects from population-based surveillance in Hunan Province, China, 2010–2020" 

  • Authors: Zhou, X. , Xie, D. , Jiang, Y. , Fang, J.
  • Journal: Scientific Reports
  • Year: 2024

"Risk factors for maternal near-miss in an undeveloped province in south-central China, 2012–2022" 

  • Authors: Zhou, X. , Fang, J. , Wu, Y. , Wang, A. , Shu, C.
  • Journal: BMC Public Health
  • Year: 2024

"Multivariate logistic regression analysis of risk factors for birth defects: a study from population-based surveillance data" 

  • Authors: Zhou, X. , He, J. , Wang, A. , Shu, C. , Fang, J.
  • Journal: BMC Public Health
  • Year: 2024

"Epidemiology of congenital polydactyly and syndactyly in Hunan Province, China" 

  • Authors: Zhou, X. , Li, T. , Kuang, H. , Fang, J. , Wang, H.
  • Journal: BMC Pregnancy and Childbirth
  • Year: 2024

Mingtao Liu | Genetic Epidemiology | Best Researcher Award

Posted on by Pencis

Dr. Mingtao Liu | Genetic Epidemiology | Best Researcher Award

First Affiliated Hospital of Guangzhou Medical University, Guangzhou | China

Author Profile

Scopus

Orcid ID

Google Scholar

🧬 Mingtao Liu: Emerging Innovator in Respiratory Medicine and Immunity Research 🧬

EARLY ACADEMIC PURSUITS 📚

Mingtao Liu began his academic journey with a B.Sc. in Forensic Science at Guangdong Medical University (2016–2021). During these years, he developed a foundation in analytical skills and scientific investigation, which later fueled his passion for medical research. Following his undergraduate studies, he pursued an M.Sc. in Clinical Laboratory Diagnostics at Guangzhou Medical University (2021–2024), where he focused on laboratory techniques essential to clinical medicine. This period not only honed his skills in diagnostics but also set the stage for his Ph.D. studies in Respiratory Medicine, emphasizing clinical applications and research into respiratory health.

PROFESSIONAL ENDEAVORS 🏆

Currently a Ph.D. candidate at Guangzhou Medical University, Mingtao specializes in respiratory medicine, with his research spanning diagnostic and prognostic biomarkers, particularly in allergic immunity. His work in multi-omics approaches to studying lung inflammation and tumor effects showcases his commitment to unraveling the molecular complexities of respiratory diseases. Mingtao’s technical skills in machine learning, data analysis, and programming languages such as Matlab and Python have empowered him to engage in cutting-edge research, particularly in big data mining and epidemiological investigation.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETIC EPIDEMIOLOGY🔍

Mingtao’s research contributions are centered on:

  1. Respiratory Immunity: He investigates diagnostic and prognostic biomarkers of respiratory immunity, focusing on allergic responses, a critical area in respiratory health.
  2. Multi-Omics Analysis: His work integrates genomics, proteomics, and metabolomics to explore mechanisms of lung inflammation and tumor development.
  3. LDT and IVD Kits: Mingtao is involved in the development of laboratory-developed tests (LDT) and in vitro diagnostic (IVD) kits based on liquid chromatography–mass spectrometry (LC-MS), providing innovative solutions for clinical diagnostics.
  4. Big Data and Epidemiology: Through epidemiological research and data mining, he is advancing our understanding of respiratory disease prevalence and risk factors.

IMPACT AND INFLUENCE 🌐

Mingtao Liu’s work has garnered recognition for its relevance and potential impact on public health. He has received notable accolades, including the European Respiratory Society 2023 Excellent Young Paper Scholarship, the National Scholarship (2023), and the Outstanding Graduate Scholarship (2024). His research contributes significantly to the development of diagnostic tools and methodologies that can potentially reshape how respiratory diseases are detected and managed, especially in the area of allergic immunity.

ACADEMIC CITES 📈

As a young researcher, Mingtao has begun building his academic footprint. His contributions are starting to be cited in relevant fields, particularly those related to respiratory medicine, allergy research, and clinical diagnostics. This early recognition in academic circles signals his growing influence as a researcher.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

Mingtao Liu’s research focus aligns with global health priorities, positioning him to make lasting contributions to the fields of respiratory health and immunology. His work on biomarkers and diagnostic kits is paving the way for more accurate, accessible, and individualized approaches to respiratory healthcare. Looking ahead, Mingtao aspires to continue his research and potentially expand into translational medicine, applying his findings to develop practical healthcare solutions that benefit patients worldwide.

ADDITIONAL TOPICS 📝

  • TECHNICAL PROFICIENCY: Mingtao possesses advanced skills in machine learning, data analysis, and programming (Python, Matlab), as well as fluency in English, Chinese, and Cantonese. These competencies enhance his ability to engage in complex research and communicate his findings to a broad audience.
  • AWARDS AND RECOGNITION: Mingtao’s scholarship awards affirm his dedication to excellence in research and academics. The European Respiratory Society award, in particular, highlights his promise as a leading voice in respiratory medicine.

NOTABLE PUBLICATIONS 📑

"Novel prediction model of early screening lung adenocarcinoma with pulmonary fibrosis based on haematological index" 

  • Authors: Li, H. , Fu, X. , Liu, M. , Cheng, Z.J. , Sun, B.
  • Journal: BMC Cancer
  • Year: 2024

"Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia" 

  • Authors: Cheng, Z.J. , Li, H. , Liu, M. , Gan, H. , Sun, B.
  • Journal: BMC Cancer
  • Year: 2024

"Interpreting epidemiologic distribution of total and specific IgE levels for food allergy in Southern China from 2004 to 2023: understanding the mechanisms and focusing on prevention" 

  • Authors: Liu, M. , Liu, L. , Qi, W. , Huang, H. , Sun, B.
  • Journal: BMC public health
  • Year: 2024

"Decoding acute myocarditis in patients with COVID-19: Early detection through machine learning and hematological indices" 

  • Authors: Li, H. , Cheng, Z.J. , Fu, X. , Wang, F. , Sun, B.
  • Journal: iScience
  • Year: 2014

"A Pilot HRCT Follow-Up Study to Test the Feasibility of Predictive Efficacy of Serum Periostin in Idiopathic Pulmonary Fibrosis" 

  • Authors: Liu, M. , Cheng, Z.J. , Chen, J. , Huang, H. , Sun, B.
  • Journal: Journal of Inflammation Research
  • Year: 2024

Yulian Ding | Molecular Basis of Genetic Disease | Best Researcher Award

Posted on by Pencis

Dr. Yulian Ding | Molecular Basis of Genetic Disease | Best Researcher Award

Shenzhen Institute of Advanced Technology | China

Author Profile

Scopus

Orcid ID

Google Scholar

🧬 YULIAN DING, PH.D. – PIONEER IN BIOMEDICAL ENGINEERING AND MACHINE LEARNING

EARLY ACADEMIC PURSUITS🎓

Yulian Ding embarked on her academic journey with a Bachelor of Science in Computer Science from Luoyang Normal University (2010-2014). Her passion for data science and bioinformatics was further solidified during her Master's degree in Computer Science at Shaanxi Normal University (2014-2017), where she focused on dynamic protein complex identification and essential protein identification through swarm intelligence optimization. Her research, under the guidance of Dr. Xiujuan Lei, shaped her understanding of computational biology and bioinformatics. In 2018, Yulian took her academic prowess to the next level by pursuing a Ph.D. in Biomedical Engineering at the University of Saskatchewan (2018-2022). Under the supervision of Dr. Fang-Xiang Wu, she developed advanced machine learning models to predict biomolecule-disease associations, working with miRNAs, lncRNAs, and circRNA.

PROFESSIONAL ENDEAVORS🧑‍🔬

Upon completing her Ph.D., Yulian Ding transitioned into various research roles that leveraged her expertise in both machine learning and biomedical engineering. From March 2022 to February 2023, she served as an Assistant Researcher at the Center for High Performance Computing, Shenzhen Institute of Advanced Technology, under the prestigious Chinese Academy of Sciences. Her work there focused on drug design and disease biomarker identification using machine learning techniques, contributing to major advancements in protein-ligand interaction prediction. Concurrently, Yulian completed a Postdoctoral Fellowship at the University of Saskatchewan’s College of Medicine and Division of Biomedical Engineering. She specialized in bio-data analytics, working on clinical data, particularly in identifying cirRNA biomarkers for cancer.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR BASIS OF GENETIC DISEASE🔬

Yulian Ding’s research focuses on biomedical informatics, particularly at the intersection of machine learning and biomolecular interaction. Her key contributions lie in:

  • Developing novel machine learning models for predicting disease-associated biomolecules, including miRNAs, lncRNAs, and circRNA.
  • Drug design and disease biomarker discovery, particularly through the integration of machine learning in protein-ligand interactions.
  • Enhancing the understanding of bio-data analytics in oncology, utilizing vast datasets to identify crucial molecular targets for treatment.

IMPACT AND INFLUENCE🌍

Ding's work has had significant implications in precision medicine, especially in the early detection of diseases through biomarker identification. Her research on biomolecule-disease associations and the use of machine learning for drug discovery has positioned her as a rising leader in the biomedical engineering field. Her collaboration with leading scientists and institutions, including her postdoctoral work, has influenced both academic research and practical applications in biotechnology.

ACADEMIC CITES📚

Yulian Ding has been recognized for her academic excellence through numerous prestigious awards:

  • Dr. Victor A. Pollak and Mirka B. Pollak Scholarship (2021, University of Saskatchewan)
  • Russell (Russ) William Haid Memorial Award (2020, University of Saskatchewan)
  • China’s National Scholarship for Graduate Students (2017)
  • China’s National Second Prize of Lanqiao Cup Software Design Competition (2014)
  • ACM Programming Competition Silver Medal (2014)

Her work has been published in leading academic journals and recognized by international peers in the fields of bioinformatics and computational biology. As a journal reviewer for notable journals like Neurocomputing, Knowledge-Based Systems, and PLOS Computational Biology, she has contributed to shaping future research trends.

LEGACY AND FUTURE CONTRIBUTIONS🔮

Yulian Ding's legacy is deeply intertwined with her pioneering work in biomedical engineering. By harnessing the power of machine learning, she has opened new avenues for disease diagnosis and drug development. Her future endeavors are poised to push the boundaries of biomedical innovation, with a continued focus on applying computational intelligence to solve biomedical challenges. Through ongoing research and collaboration, Yulian will undoubtedly remain at the forefront of biomedical science, contributing to innovations that bridge the gap between computation and medicine.

 FINAL THOUGHTS🏅

Yulian Ding's academic journey, professional achievements, and innovative research establish her as a significant figure in biomedical engineering. Her work continues to make impactful contributions to precision medicine and biomedical informatics, shaping the future of healthcare through cutting-edge machine learning applications.

NOTABLE PUBLICATIONS📑

"MRDPDA: A multi-Laplacian regularized deepFM model for predicting piRNA-disease associations" 

  • Authors: Liu, Y. , Zhang, F. , Ding, Y. , Li, J. , Wu, F.-X.
  • Journal: Cellular and Molecular Medicine
  • Year: 2024

"P4PC: A Portal for Bioinformatics Resources of piRNAs and circRNAs" 

  • Authors: Liu, Y., Li, R., Ding, Y., Hei, X., Wu, F.-X.
  • Journal: Bioinformatics
  • Year: 2024

"Negative sample selection for miRNA-disease association prediction models" 

  • Authors: Ding, Y. , Wang, F. , Zhang, Y. , Wu, F.-X.
  • Journal: Machine Learning Methods for Multi-Omics Data Integration
  • Year: 2023

"Biomarker Identification via a Factorization Machine-Based Neural Network With Binary Pairwise Encoding" 

  • Authors: Ding, Y. , Lei, X. , Liao, B. , Wu, F.-X
  • Journal: IEEE/ACM Transactions on Computational Biology and Bioinformatics
  • Year: 2023

"MLRDFM: a multi-view Laplacian regularized DeepFM model for predicting miRNA-disease associations" 

  • Authors: Ding, Y. , Lei, X. , Liao, B. , Wu, F.-X
  • Journal: Briefings in Bioinformatics
  • Year: 2022

Flavio Faletra | Cardiovascular Genetics and Genomics | Best Researcher Award 

Posted on by Pencis

Dr. Flavio Faletra | Cardiovascular Genetics and Genomics | Best Researcher Award 

University Health Authority of Central Friuli | Italy

Author Profile

Scopus
Orcid ID

Biography of Flavio Faletra: A Leader in Medical Genetics 🧬

EARLY ACADEMIC PURSUITS 🎓

Flavio Faletra began his distinguished academic journey at the University of Trieste, where he earned a Degree in Medicine and Surgery in 2005. He further specialized in Medical Genetics at the same institution, completing his specialization in 2009. Demonstrating a strong commitment to his field, Faletra pursued advanced education with a Second-level Master’s degree in Clinical Genetics from the University of Siena in 2011. His foundational academic achievements laid the groundwork for a career focused on the intersection of genetics and clinical medicine.

PROFESSIONAL ENDEAVORS 🏥

Flavio Faletra has held multiple pivotal roles in medical genetics. Since August 2023, he has been an Expert in Genetics at the Regional Health Coordination Agency (ARCS) in Friuli Venezia Giulia, Italy. Alongside his expert role, he has been a University Lecturer on contract at the University of Trieste from 2018 to 2023, contributing to the academic growth of students in the field of genetics. His professional journey includes numerous positions as a Medical Director I Level in Medical Genetics, starting with the IRCCS Burlo Garofolo (2013–2017) and progressing through roles in University Health Authority Friuli Centrale and IRCCS Burlo Garofolo until his current position, reflecting his leadership in the medical genetics field.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR GENETICS AND GENOMICS  🔬

Faletra’s research focus spans various critical areas of medical genetics, from pediatric endocrinology to rare genetic diseases. He has contributed extensively to genetic counseling and clinical genetics, with a strong emphasis on pediatric genetic disorders. His work as a Thesis Co-Surveyor and PhD Supervisor at the University of Trieste demonstrates his dedication to nurturing the next generation of geneticists. Through courses such as the Genetic Consulting in Medical Genetics Specialization School, he has shaped the landscape of medical genetics education. His involvement in pediatric endocrinology through ADE courses has brought syndromic genetic disorders to the forefront, significantly impacting the medical community’s approach to these conditions.

IMPACT AND INFLUENCE 🌍

Faletra’s influence extends beyond academia into clinical practice, where his expertise has helped shape genetic diagnostic strategies across Italy. His participation in national conferences, such as the National Congress of Human Genetics and seminars on genetic syndromes and diagnostics, marks him as a key figure in Italian medical genetics. Faletra's teaching and research efforts have particularly impacted the areas of growth retardation, fetal malformations, and syndromic genetic disorders, positioning him as a central figure in advancing genetic medicine in pediatrics.

ACADEMIC CITES 📚

Flavio Faletra's work has been cited in numerous academic publications, with topics ranging from genetic diagnostic methods to therapeutic approaches for rare genetic disorders. His research in exome sequencing and next-generation sequencing techniques has had a broad impact, being referenced widely in the fields of human genetics and pediatric medicine.

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Faletra’s legacy lies in his dedication to medical genetics, particularly in the areas of pediatric syndromic diseases and clinical genetics. His contribution to education, research, and clinical practice has left an indelible mark on the field. Looking ahead, his ongoing role as an expert and lecturer promises continued contributions to genomic medicine and the advancement of personalized treatment for genetic disorders. Through his continuous involvement in research, teaching, and clinical practice, Faletra remains at the forefront of innovation in medical genetics, with the potential to further revolutionize the diagnosis and treatment of complex genetic diseases.

NOTABLE PUBLICATIONS 📑

"SRSF1 haploinsufficiency is responsible for a syndromic developmental disorder associated with intellectual disability" 

  • Authors: Bogaert, E., Garde, A., Gautier, T., Dermaut, B., Vitobello, A.
  • Journal: American Journal of Human Genetics
  • Year: 2023

"Haploinsufficiency as a Foreground Pathomechanism of Poirer-Bienvenu Syndrome and Novel Insights Underlying the Phenotypic Continuum of CSNK2B-Associated Disorders" 

  • Authors:Di Stazio, M., Zanus, C., Faletra, F., d’Adamo, A.P., Musante, L.
  • Journal: Genes
  • Year: 2023

"A new neurodevelopmental disorder linked to heterozygous variants in UNC79"

  • Authors: A., Liu, Z., Luo, S., Liao, W., & Ren, D.
  • Journal: Genetics in Medicine
  • Year: 2023

"The clinical impact of the first-trimester nuchal translucency between the 95th–99th percentiles"

  • Authors: Fantasia, I., Catagini, S., Zamagni, G., Feresin, A., & Stampalija, T.
  • Journal: Prenatal Diagnosis
  • Year: 2023

"A bird’s eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases"

  • Authors: Zucco, J., Baldan, F., Allegri, L., Damante, G., Mio, C.
  • Journal: Journal of Human Genetics
  • Year: 2024

Erisa Mwaka | Genetics and Genomics | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Erisa Mwaka | Genetics and Genomics | Best Researcher Award

Makerere University | Uganda

AUTHOR PROFILE

Orcid ID

EARLY ACADEMIC PURSUITS

Mwaka Erisa Sabakaki's academic journey began at Mwiri Primary School, where he earned his Primary Leaving Examination Certificate in 1986. He continued his education at Busoga College Mwiri, obtaining the Uganda Certificate of Education in 1990 and the Uganda Advanced Certificate of Education in 1992. He pursued a Bachelor of Medicine and Bachelor of Surgery at Makerere University, Kampala, from 1992 to 1997. Following this, he achieved a Master of Medicine in Orthopaedic Surgery from Makerere University between 2000 and 2003, where his thesis focused on the clinical and radiological presentation of osteonecrosis of the femoral head among sickle cell patients. He furthered his academic credentials with a Doctor of Philosophy in Medical Science from Fukui University School of Medicine in Japan, concentrating on histo-pathological and immuno-histological findings related to calcium pyrophosphate dihydrate crystal deposition in the ligamentum flavum of the cervical spine.

PROFESSIONAL ENDEAVORS

Mwaka's professional career is multifaceted, combining academic responsibilities, clinical practice, and extensive involvement in research ethics. Since December 2020, he has been an Associate Professor at Makerere University College of Health Sciences, School of Biomedical Sciences, Department of Anatomy. His clinical practice includes serving as an orthopaedic and spine surgeon at Mulago National Referral and Teaching Hospital. Additionally, he has held significant roles, such as the Chair of the Makerere University School of Biomedical Sciences Higher Degrees Research Ethics Committee (SBSHREC), where he oversees the regulation of research involving human participants and study animals.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETICS AND GENOMICS 

Mwaka's contributions to the medical field are substantial, particularly in the areas of anatomy, orthopaedics, bioethics, and health research ethics. He has a notable interest in spine conditions, occupational health, bone health in HIV, and the ethics of medical care, biobanking, and genomics. His research includes supervising graduate studies and conducting his own investigations, with a significant focus on ethical standards and the responsible conduct of research. He is a key member and co-investigator in various training programs, including the Fogarty-funded International Health Ethics Training (IHRET) master's program.

IMPACT AND INFLUENCE

Mwaka has been recognized for his significant contributions to medical education, clinical care, and research. He is a member of multiple professional organizations, including the Uganda Medical Association, Association of Surgeons of Uganda, Uganda Orthopaedic Association, and International Society of Orthopaedic Surgery and Traumatology (SICOT). His involvement in these organizations has enhanced his professional skills and fostered teamwork and communication within the medical community.

AWARDS AND HONORS

Mwaka's excellence in his field has been acknowledged through numerous awards and honors. Notably, he received the Prof. Medi Kawuma Excellence in Medical Ethics Award in 2023 from the Uganda Medical Association, recognizing his outstanding contributions to research, clinical care, and medical education. He has also been honored by the Uganda Orthopaedic Association and the South African Research Ethics Training Initiative (SARETI) for his academic and professional achievements.

ACADEMIC SITES

Mwaka has actively contributed to multiple technical advisory committees and data and safety management boards. His roles include overseeing studies on severe acute malnutrition, HIV outcomes improvement using mobile phone-based support, growth and development in stunted children, clinical trials on natural therapeutics, and respiratory interventions. His work in these areas underscores his dedication to improving health outcomes through research and ethical oversight.

LEGACY AND FUTURE CONTRIBUTIONS

Mwaka's legacy is marked by his dedication to education, clinical excellence, and ethical research practices. His contributions have significantly advanced the fields of orthopaedics, bioethics, and health research ethics. Moving forward, his continued involvement in mentoring and training future medical professionals and researchers will further solidify his impact on the medical community. His role in developing and implementing ethical guidelines for clinical research will ensure the responsible conduct of research and the protection of participants' rights and welfare.

NOTBLE PUBLICATIONS

Informed consent in cancer clinical care: Perspectives of healthcare professionals on information disclosure at a tertiary institution in Uganda 2024(1)

Evaluation of the current status of prosthetic rehabilitation services for major limb loss: a descriptive study in Ugandan Referral hospitals 2024(2)

Research Participants’ Preferences for Individual Results of Pharmacogenomics Research: A Case of a Ugandan HIV Research Institute 2023(2)

A case for routine microbial diagnostics: Results from antimicrobial susceptibility testing in post-traumatic wound infections at a Ugandan tertiary care hospital 2023(2)

Remote consent approaches for mobile phone surveys of non-communicable disease risk factors in Colombia and Uganda: A randomized study2023(1)